| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Harvard Apparatus Regenerative Technology, Inc. (HRGN) has 8 insiders with recent SEC Form 4 filings, including 12 buys and 0 sells. HRGN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 280.6K | $420.9K | - | |
| Dir | 18.6K | $27.9K | - | |
| Dir | 18.6K | $27.9K | - | |
| Dir | 18.6K | $27.9K | - | |
| Dir | 18.6K | $27.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 12, 2022 | Dst Capital LLC | 10% Owner | Buy | 8,277 | $5.92 | $48,999.84 | +0.2% | |
| May 12, 2022 | Shmerling James E. | Director | Buy | 16,892 | $5.92 | $100,000.64 | New | |
| Nov 26, 2021 | Green David | Interim CEO | Buy | 72,464 | $3.45 | $250,000.80 | +314.4% | |
| Sep 1, 2021 | Dst Capital LLC | 10% Owner | Buy | 500,000 | $2.00 | $1,000,000.00 | +15.9% | |
| Jun 17, 2021 | Dst Capital LLC | 10% Owner | Buy | 150,000 | $2.00 | $300,000.00 | +5.0% | |
| Jul 12, 2018 | Dst Capital LLC | 10% Owner | Buy | 5,000 | $4.00 | $20,000.00 | +19.4% | |
| Jun 29, 2018 | Du Xiaoyu | 10% Owner | Buy | 250,000 | $3.60 | $900,000.00 | +50.0% | |
| Jun 15, 2018 | McNaughton Thomas | Chief Financial Officer | Buy | 2,500 | $4.40 | $11,000.00 | +22.3% | |
| Jun 15, 2018 | Yu Hong | President | Buy | 19,350 | $4.42 | $85,464.05 | +29.8% | |
| Jun 13, 2018 | Yu Hong | President | Buy | 22,650 | $3.82 | $86,477.50 | +83.8% |